Pacira Pharmaceuticals buy Truist Financial Co.
Start price
25.07.24
/
50%
€18.40
Target price
25.07.25
€27.62
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 25.07.25. The prediction end date can be changed by Truist_Financial_Co_ at any time.Performance without dividends (%)
| Name | 1w |
|---|---|
| Pacira Pharmaceuticals | - |
| iShares Core DAX® | -0.612% |
| iShares Nasdaq 100 | -3.018% |
| iShares Nikkei 225® | -2.647% |
| iShares S&P 500 | -1.932% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Pacira Pharmaceuticals diskutieren
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its price target lowered by analysts at Truist Financial Co. from $45.00 to $30.00. They now have a "buy" rating on the stock.
Ratings data for PCRX provided by MarketBeat